Steven R Jones Selected Research

lipoprotein cholesterol

7/2019	Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids.
5/2018	Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial.
3/2016	Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-term Phase IV PREVAIL US Trial in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia.
1/2016	Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
11/2015	Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH Registry.
7/2015	Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.
4/2014	Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven R Jones Research Topics

Disease

35	Cardiovascular Diseases (Cardiovascular Disease) 04/2023 - 01/2012
18	Dyslipidemias (Dyslipidemia) 04/2022 - 07/2013
17	Atherosclerosis 04/2023 - 11/2010
13	Inflammation (Inflammations) 03/2023 - 01/2014
9	Coronary Disease (Coronary Heart Disease) 01/2022 - 07/2013
8	Coronary Artery Disease (Coronary Atherosclerosis) 03/2023 - 01/2011
8	Myocardial Infarction 03/2023 - 10/2009
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2023 - 09/2015
5	Obesity 04/2023 - 07/2013
5	Insulin Resistance 01/2021 - 04/2013
5	Stroke (Strokes) 01/2019 - 01/2012
4	Diabetes Mellitus 01/2022 - 10/2016
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 09/2015
4	Type 2 Diabetes Mellitus (MODY) 04/2021 - 04/2016
4	Hypercholesterolemia 01/2020 - 07/2012
3	Acute Coronary Syndrome 03/2023 - 05/2018
3	Hypertriglyceridemia 01/2018 - 01/2012
2	Non-ST Elevated Myocardial Infarction 03/2023 - 01/2022
2	ST Elevation Myocardial Infarction 03/2023 - 01/2022
2	Hypertension (High Blood Pressure) 01/2023 - 01/2019
2	Atherosclerotic Plaque (Atheroma) 01/2020 - 01/2016
2	Ischemic Stroke 05/2018 - 12/2017
2	Hyperlipidemias (Hyperlipidemia) 01/2018 - 03/2016
2	Atrial Fibrillation 12/2017 - 01/2011
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 06/2015 - 03/2015
2	Myalgia 01/2015 - 01/2015
1	Carotid Stenosis (Carotid Artery Stenosis) 10/2023
1	Kidney Diseases (Kidney Disease) 01/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Infarction (Infarctions) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2021
1	Rupture 12/2020
1	Stable Angina 11/2020
1	Left Ventricular Dysfunction 11/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 11/2020
1	Endocarditis 01/2020
1	Homozygous Familial Hypercholesterolemia 10/2019
1	Abdominal Obesity 01/2019
1	Neoplasms (Cancer) 01/2019
1	Thrombosis (Thrombus) 05/2018
1	Breast Neoplasms (Breast Cancer) 07/2017
1	Vitamin D Deficiency 06/2017
1	Abdominal Aortic Aneurysm 02/2017
1	Sudden Death 12/2016

Drug/Important Bio-Agent (IBA)

20	Lipoproteins (Lipoprotein)IBA 04/2023 - 04/2013
20	LipidsIBA 04/2022 - 07/2013
16	Triglycerides (Triacylglycerol)IBA 04/2023 - 04/2013
15	HDL CholesterolIBA 10/2020 - 01/2014
15	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2011
14	CholesterolIBA 04/2023 - 07/2012
12	oxidized low density lipoproteinIBA 01/2023 - 04/2013
11	Lipoprotein(a)IBA 03/2023 - 10/2009
11	LDL CholesterolIBA 01/2022 - 06/2014
7	C-Reactive ProteinIBA 10/2023 - 01/2017
7	Apolipoproteins B (ApoB)IBA 01/2021 - 01/2016
7	lipoprotein cholesterolIBA 07/2019 - 04/2014
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 11/2013
4	evolocumabIBA 03/2023 - 01/2018
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 09/2015
4	HDL LipoproteinsIBA 01/2022 - 01/2016
4	ApolipoproteinsIBA 01/2020 - 01/2018
4	CalciumIBA 01/2019 - 02/2012
4	Vitamin D FDA LinkGeneric 06/2017 - 01/2015
3	Proprotein Convertase 9IBA 01/2022 - 10/2018
2	AdiponectinIBA 04/2023 - 10/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2014
2	25-hydroxyvitamin DIBA 06/2017 - 06/2017
2	hydroxide ionIBA 06/2017 - 06/2017
2	Complement System Proteins (Complement)IBA 06/2015 - 03/2015
1	Glycoproteins (Glycoprotein)IBA 10/2023
1	Hormones (Hormone)IBA 04/2023
1	LeptinIBA 04/2023
1	ResistinIBA 04/2023
1	AdipokinesIBA 04/2023
1	SodiumIBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	Troponin IIBA 01/2022
1	Amino Acids FDA Link 04/2021
1	InterleukinsIBA 12/2020
1	CytokinesIBA 12/2020
1	AntibodiesIBA 01/2020
1	IceIBA 01/2020
1	Vasodilator Agents (Vasodilators)IBA 01/2020
1	Uric Acid (Urate)IBA 01/2019
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019
1	LDL Receptors (LDL Receptor)IBA 10/2018
1	Fibric Acids (Fibrates)IBA 09/2018
1	Niacin (Nicotinic Acid)FDA LinkGeneric 05/2018
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2018
1	Coenzyme A (CoA)IBA 01/2018
1	Tamoxifen FDA LinkGeneric 07/2017
1	Selective Estrogen Receptor Modulators (SERM)IBA 07/2017
1	HDL-triglycerideIBA 04/2016

Therapy/Procedure

15	Therapeutics 04/2022 - 11/2010
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2016 - 06/2013
2	Secondary Prevention 01/2015 - 01/2014
1	Mechanical Ventilators (Ventilator) 01/2022
1	Glycemic Control 04/2016